- Home
- QURE vs BILL Comparison
QURE vs BILL Comparison
Compare QURE & BILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | BILL |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.2B |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | QURE | BILL |
|---|---|---|
| Price | $43.04 | $50.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 21 |
| Target Price | $45.00 | ★ $57.90 |
| AVG Volume (30 Days) | 1.1M | ★ 2.0M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $13,107,000.00 | ★ $1,653,160,000.00 |
| Revenue This Year | $126.12 | $14.18 |
| Revenue Next Year | $200.43 | $13.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 13.03 |
| 52 Week Low | $8.73 | $31.41 |
| 52 Week High | $71.50 | $57.21 |
Technical Indicators
Market Signals| Indicator | QURE | BILL |
|---|---|---|
| Relative Strength Index (RSI) | 46.24 | 56.31 |
| Support Level | $39.50 | $35.27 |
| Resistance Level | $51.09 | $50.25 |
| Average True Range (ATR) | 2.05 | 1.68 |
| MACD | -0.66 | -0.27 |
| Stochastic Oscillator | 21.68 | 73.99 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About BILL BILL Holdings Inc.
BILL Holdings Inc is a provider of software-as-a-service, cloud-based payments and spend and expense management products, which allow users to automate accounts payable and accounts receivable transactions, enable businesses to easily connect with their suppliers or customers to do business, eliminate expense reports, manage cash flows and improve back office efficiency. Initial Public Offering and Follow-on Offering.